Proxima
Latest round
- Seed
Last raised
- Jan 2026
Total raised
- $80M
Investors
- 9
About Proxima
Founded in 2019 in New York, Proxima focuses on advanced drug discovery methodologies. The most recent deal occurred on January 13, 2026.Proxima specializes in advanced AI-driven drug discovery, focusing on the development of proximity-based therapeutic modalities. Its core offerings include technologies designed to enhance data generation for drug discovery, which are pivotal in addressing complex scientific challenges in the pharmaceutical industry. The company has engaged in collaborations with Halda Therapeutics and Blueprint Medicines, indicating a commitment to pioneering next-generation medicines, particularly in the RIPTAC domain.Proxima's revenue model is robust, centered around strategic partnerships and research collaborations, exemplified by a significant agreement with Halda Therapeutics with a total potential value exceeding USD 1 bn. The company conducts B2B transactions primarily with pharmaceutical firms and research organizations, providing proprietary platforms and technologies that enhance drug discovery efforts. Proxima is also strategizing to introduce new products designed for the drug discovery market and aims to expand its operations into additional geographic regions across Europe by the end of 2026.
Who invested in Proxima
9 investors across 1 round
See all investors in Proxima
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jan 13, 2026
Amount
$80M
Investors
Questions about Proxima
Who invested in Proxima?
Proxima has 9 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Proxima raised?
Proxima has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Proxima last raise money?
Proxima's most recent round on record is a Seed, in Jan 2026.
What does Proxima do?
Founded in 2019 in New York, Proxima focuses on advanced drug discovery methodologies.
Where is Proxima headquartered?
Proxima is headquartered in New York, US.
Which VCs invest in companies like Proxima?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Proxima's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Proxima? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.